U.S. Markets closed
  • S&P 500

    3,970.99
    +22.27 (+0.56%)
     
  • Dow 30

    32,237.53
    +132.28 (+0.41%)
     
  • Nasdaq

    11,823.96
    +36.56 (+0.31%)
     
  • Russell 2000

    1,734.92
    +14.63 (+0.85%)
     
  • Crude Oil

    69.20
    -0.76 (-1.09%)
     
  • Gold

    1,981.00
    -14.90 (-0.75%)
     
  • Silver

    23.36
    +0.11 (+0.47%)
     
  • EUR/USD

    1.0763
    -0.0073 (-0.6781%)
     
  • 10-Yr Bond

    3.3800
    -0.0260 (-0.76%)
     
  • Vix

    21.74
    -0.87 (-3.85%)
     
  • GBP/USD

    1.2232
    -0.0057 (-0.4624%)
     
  • USD/JPY

    130.6700
    -0.1190 (-0.0910%)
     
  • BTC-USD

    27,534.65
    -37.02 (-0.13%)
     
  • CMC Crypto 200

    597.33
    -21.06 (-3.41%)
     
  • FTSE 100

    7,405.45
    -94.15 (-1.26%)
     
  • Nikkei 225

    27,385.25
    -34.36 (-0.13%)
     

Medivation price target raised to $93 from $85 at Brean Murray

Brean Murray raised its price target on Medivation following Q1 results. The company reported record revenues and expects enzalutimide to launch in Q4 adding to revenues. Shares are Buy rated.